Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00877136 · ClinicalTrials.gov registry record
A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®
A clinical trial, sponsored by St. Joseph Hospital of Orange.
- Completed
- Registry status
- 18
- Enrollment target
NCT00877136: Completed study, sponsored by St. Joseph Hospital of Orange.
NCT00877136 is a clinical trial that has completed, run by St. Joseph Hospital of Orange. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00877136 has completed, sponsored by St. Joseph Hospital of Orange.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
This is an interdisciplinary study that falls into the Humanitarian Use Device category. There are no hypotheses to be tested in this treatment protocol. The study has the following objectives: 1. Provide supervised access to treatment with TheraSphere® to eligible patients with primary cancer to the liver who are not surgical resection candidates. 2. Evaluate patient experience and toxicities associated with TheraSphere® treatment. 3. Measure tumor response rates
Primary Outcome
The number of eligible patients provided with supervised access to treatment with TheraSphere with primary cancer to the liver who are not surgical resection candidates.
Interventions
- DEVICE TheraSphere®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2009-02 |
| Est. Completion | 2021-03 |
What the finished NCT00877136 record still lists
NCT00877136 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which TheraSphere® is the first listed.
NCT00877136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00877136 about?
NCT00877136 is a clinical study titled "A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®". This is an interdisciplinary study that falls into the Humanitarian Use Device category. There are no hypotheses to be tested in this treatment protocol. The study has the following objectives: 1. Provide supervised access to treatment with TheraSphere® to eligible patients with primary cancer to t...
What is the current status of trial NCT00877136?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2009-02. Estimated completion is 2021-03.
What interventions are being tested in trial NCT00877136?
The interventions under investigation include: TheraSphere® (DEVICE).
Who is sponsoring clinical trial NCT00877136?
This trial is sponsored by St. Joseph Hospital of Orange, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia